首页> 美国卫生研究院文献>Journal of Korean Medical Science >Patterns of Antipsychotic Prescription to Patients with Schizophrenia in Korea: Results from the Health Insurance Review Assessment Service-National Patient Sample
【2h】

Patterns of Antipsychotic Prescription to Patients with Schizophrenia in Korea: Results from the Health Insurance Review Assessment Service-National Patient Sample

机译:韩国精神分裂症患者的抗精神病药处方模式:健康保险审查与评估服务的结果-全国患者样本

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to analyze the patterns of antipsychotic prescription to patients with schizophrenia in Korea. Using the Health Insurance Review & Assessment Service-National Patients Sample (HIRA-NPS), which was a stratified sampling from the entire population under the Korean national health security system (2009), descriptive statistics for the patterns of the monopharmacy and polypharmacy, neuropsychiatric co-medications, and prescribed individual antipsychotic for patients with schizophrenia were performed. Comparisons of socioeconomic and clinical factors were performed among patients prescribed only with first- and second-generation antipsychotics. Of 126,961 patients with schizophrenia (age 18-80 yr), 13,369 were prescribed with antipsychotic monopharmacy and the rest 113,592 with polypharmacy. Two or more antipsychotics were prescribed to 31.34% of the patients. Antiparkinson medications (66.60%), anxiolytics (65.42%), mood stabilizers (36.74%), and antidepressants (25.90%) were co-medicated. Patients who were prescribed only with first-generation antipsychotics (n=26,254) were characterized by significantly older age, greater proportion of male, higher proportion of medicaid, higher total medical cost, lower self-payment cost, and higher co-medication rates of antiparkinson agents and anxiolytics than those who were prescribed only with second-generation antipsychotics (n=67,361). In this study, it has been reported substantial prescription rates of first-generation antipsychotics and antipsychotic polypharmacy and relatively small prescription rate of clozapine to patients with schizophrenia. Since this study has firstly presented the patterns of antipsychotic prescription to schizophrenic patients in Korean national population, the findings of this study can be compared with those of later investigations about this theme.Graphical Abstract
机译:这项研究旨在分析韩国精神分裂症患者的抗精神病药处方模式。使用健康保险审查与评估服务的国家患者样本(HIRA-NPS),这是在韩国国家健康安全体系下(2009年)从整个人群中抽取的分层样本,用于描述单一药房和多药房模式,神经精神病学模式的描述性统计数据进行联合用药,并为精神分裂症患者开具单独的抗精神病药。在仅使用第一代和第二代抗精神病药的患者中进行了社会经济和临床因素的比较。在126,961例精神分裂症患者(年龄18-80岁)中,有13,369例接受了抗精神病药物的处方,其余113,592例则接受了多元药物的处方。 31.34%的患者开了两种或两种以上抗精神病药。联合使用抗帕金森药物(66.60%),抗焦虑药(65.42%),情绪稳定剂(36.74%)和抗抑郁药(25.90%)。仅使用第一代抗精神病药的患者(n = 26,254)的特征是年龄大得多,男性比例更高,医疗补助比例更高,总医疗费用更高,自费成本更低,且联合用药率更高与仅使用第二代抗精神病药处方的患者相比(n = 67,361)。在这项研究中,已经报道了第一代抗精神病药和抗精神病多药的处方率很高,而氯氮平对精神分裂症患者的处方率相对较小。由于本研究首次向朝鲜族人群的精神分裂症患者介绍了抗精神病处方的模式,因此该研究的发现可以与以后对该主题进行的研究进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号